​

Funding Round

Series D - Element Biosciences

Series D - Element Biosciences

Investment Firm

Overview

Element Biosciences is a life science company that focuses on developing innovative genetic analysis tools.

Announced Date

Jul 11, 2024

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Wellington Management

Wellington Management

Wellington Management is a debt and early_stage_venture and late_stage_venture and private_equity and venture firm.

Participant Investors

6

Investor Name
Participant InvestorT. Rowe Price
Participant InvestorVenrock
Participant InvestorSamsung Electronics
Participant InvestorWellington Management
Participant InvestorFidelity

Round Details and Background

Element Biosciences raised $277000000 on 2024-07-11 in Series D

Element Biosciences is a life science company that focuses on developing innovative genetic analysis tools.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 09, 2020
Series B - Element Biosciences
4-80.0M
Jun 26, 2020
Series B - Element Biosciences
2-30.0M
Jun 29, 2021
Series C - Element Biosciences
10-276.0M
Jul 11, 2024
Series D - Element Biosciences
6-277.0M

Recent Activity

There is no recent news or activity for this profile.